PEYS606 not checked

Eyevensys

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“pEYS606 is a DNA plasmid solution administered by electrotransfection into the ciliary muscle”In the company’s words, NCT03308045 on ClinicalTrials.gov
Tested for
Non-infectious Uveitis
Main trialPhase 1/2
“Primary objective: safety and tolerability Secondary objectives: additional indicators of long term safety and indicators of clinical activity Exploratory objectives: to characterize EYS606 biodistribution, immunogenicity and biomarkers”In the company’s words, NCT03308045 on ClinicalTrials.gov

Other drugs for Non-infectious Uveitis

All 9 drugs for Non-infectious Uveitis

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1/2Completed 1 Jun 2021 Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow PEYS606

Following is part of Solo: you see every change to PEYS606 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in